CREBBP and prostate carcinoma: We observed a similar effect of I-CBP112, which targets the CBP/EP300 bromodomain, on the mitotic division in a culture of MDA-MB-231, whereas a substantial reduction in c-MYC, which is considered a TNBC driver, was observed in prostate cancer [9].